Cipla to pick 14.6% stake in Chase Pharmaceuticals for $1.5m

Drug firm Cipla Ltd today said it will acquire 14.6 per cent stake in

RELATED ARTICLES

US-based Chase Pharmaceuticals Corporation Inc for USD 1.5 million.

The investment will be done through Cipla's wholly owned subsidiary Cipla (EU) Ltd, UK.

Cipla also said it will make an additional USD 4.5 million investment in Chase upon achievement of certain milestones.

"..Company has signed a definitive agreement to invest USD 1.5 million in Chase Pharmaceuticals Corporation Inc, US, to acquire 14.6 per cent stake in Chase on a fully diluted basis," Cipla said in a BSE filing.

Chase is an early stage drug development company, engaged in novel approaches to improve treatments for Alzheimer's disease.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.

EDITORIAL OF THE DAY

  • Swift action plan may combat adverse effects of bad monsoon

    The bad news is out.

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Simon J Evenett

Is it the end game for Greece?

Five months after the election of a left-wing government on ...

Zehra Naqvi

Green peace is key to overall wellbeing

Why do people head for the hills to recharge and ...

Dharmendra Khandal

Social media is not always a blessing

There is, perhaps, a misconception that social media is a ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture